NBIX — NEUROCRINE BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 914475 ·
Last close
$138.40
Market Cap
$14.07B
52W High
$186.12
52W Low
$122.14
ADV30
1,150,083
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 959,000,000 | 935,800,000 | 153,000,000 | 144,400,000 | 5,359,100,000 | 332,400,000 | 1,665,500,000 |
| Mar 2026 | 814,500,000 | 800,700,000 | 186,000,000 | 197,900,000 | 4,906,200,000 | 266,500,000 | 1,498,800,000 |
| Dec 2025 | 805,500,000 | 787,900,000 | 227,900,000 | 153,700,000 | 4,631,500,000 | 713,000,000 | 1,378,400,000 |
| Sep 2025 | 794,900,000 | 780,900,000 | 239,300,000 | 209,500,000 | 4,265,700,000 | 340,200,000 | 1,262,100,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$898,100,000
Investing CF
$-891,200,000
Financing CF
$60,200,000
CapEx
$-42,600,000
Dividends Paid
—
Buybacks
$-66,000,000
EPS Diluted TTM
$6.82
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$724,000,000
Inventory
$104,200,000
Receivables
$887,000,000
ST Investments
$57,400,000
EBIT TTM
$818,300,000
Pretax Income TTM
$940,200,000
Interest Exp TTM
$2,900,000
Analysts
27
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,373,900,032
EBITDA
$913,299,968
Free Cash Flow
$638,237,504
Enterprise Value
$15,951,434,752
Total Cash
$389,800,000
Total Debt
$461,600,000
Shares Out
101,649,181
Trailing EPS
$6.84
Book Value
$36.35
ROE
22.1%
ROA
11.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,860,500,000 | 636,500,000 | 478,600,000 | 4,631,500,000 | 1,378,400,000 | 3,253,100,000 | 782,700,000 |
| Dec 2024 | 2,355,300,000 | 583,000,000 | 341,300,000 | 3,718,700,000 | 1,129,000,000 | 2,589,700,000 | 595,400,000 |
| Dec 2023 | 1,887,100,000 | 394,800,000 | 249,700,000 | 3,251,400,000 | 1,019,400,000 | 2,232,000,000 | 389,900,000 |
| Dec 2022 | 1,488,700,000 | 249,000,000 | 154,500,000 | 2,368,700,000 | 660,900,000 | 1,707,800,000 | 339,400,000 |
TTM Snapshot
Revenues TTM
$2,081,400,000
NetIncome TTM
$289,300,000
OpCashFlow TTM
$0
Assets (Latest)
$4,631,500,000
Forward EPS
$11.97
Max Pain — expiry 2026-12-18
max pain strike: $155.00 · spot: $137.11 · call oi: 1,745 · put oi: 3,277
Expected Move to 2026-12-18:
±$27.00
(19.69%) —
implied range
$110.11 –
$164.11
· ATM straddle on $135.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| EXEL | EXELIXIS, INC. | $14.41B | $58.16 | — |
| HALO | HALOZYME THERAPEUTICS, INC. | $12.93B | $113.90 | — |
| TWST | Twist Bioscience Corp | $12.12B | $182.83 | — |
| TECH | BIO-TECHNE Corp | $11.39B | $72.61 | — |
| RGEN | REPLIGEN CORP | $10.70B | $189.68 | — |
News headlines (Yahoo Finance, 1h cache)
Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price Hit
2026-09-23 04:02 · Yahoo
Neurocrine’s (NBIX) Data Deluge Reshapes A Familiar Growth Story
2026-09-18 04:47 · Yahoo
Neurocrine Biosciences' Ingrezza, Crenessity to Drive H2 Ahead of 'Catalyst-Rich' 2027, RBC Says
2026-09-08 15:50 · Yahoo
Neurocrine Biosciences to Present at Upcoming Investor Conferences in September
2026-09-02 20:01 · Yahoo
Neurocrine Biosciences (NBIX) Wins FDA Trial Nod, Is It Still Below Fair Value?
2026-08-28 02:18 · Yahoo
Neurocrine Biosciences (NBIX) Stock Looks Fairly Priced As 64% Gain Holds
2026-08-27 12:14 · Yahoo
Is NBIX Stock a Buy as Fast Growth Meets a Premium Sales Valuation?
2026-08-20 15:14 · Yahoo
NBIX Stock Slips As $2.9B Soleno Deal Triggers Fresh Drug Safety Warnings
2026-08-12 23:42 · Yahoo
Neurocrine Biosciences shares fall amid Vykat safety concerns
2026-08-12 13:38 · Yahoo
Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living wi
2026-08-12 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.